NCT03826927View on ClinicalTrials.gov

New Oral Anticoagulants (NOAC) in Stroke Patients

CompletedOBSERVATIONAL
Enrollment

1,023

Participants

Timeline

Start Date

March 1, 2013

Primary Completion Date

August 31, 2021

Study Completion Date

August 31, 2021

Conditions
StrokeAtrial Fibrillation
Interventions
OTHER

treatment with NOACs or VKAs

treatment with NOACs or VKAs initiated or continued for prevention of ischemic events

Trial Locations (2)

4002

Felix Platter Spital, Basel

4031

Dep. of Neurology, Hospital of the University of Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03826927 - New Oral Anticoagulants (NOAC) in Stroke Patients | Biotech Hunter | Biotech Hunter